Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/incretin-based-drugs-show-superior-glycemic-profiles-cgm-2026a1000bxo?src=rss
Author :
Publish date : 2026-04-16 13:03:00
Copyright for syndicated content belongs to the linked Source.
